Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Beatriz Asenjo"'
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, Ana Ortiz de Mendivil, Beatriz Asenjo, David Albillo, Luís A. Pérez-Romasanta, Manuel LLorente, Natalia Carballo, Estanislao Arana, Víctor M. Pérez-García
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Stereotactic radiotherapy is the preferred treatment for managing patients with fewer than five brain metastases (BMs). However, some lesions recur after irradiation. The purpose of this study was to identify patients who are at a
Externí odkaz:
https://doaj.org/article/74349e88ae224154b5f64bc16b56cfc7
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, Juan Jiménez-Sánchez, David Molina-García, Ana Ortiz de Mendivil, Beatriz Asenjo, David Albillo, Luis A. Pérez-Romasanta, Manuel Valiente, Lucía Zhu, Pedro García-Gómez, Elisabet González-Del Portillo, Manuel Llorente, Natalia Carballo, Estanislao Arana, Víctor M. Pérez-García
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-11 (2023)
Abstract Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple
Externí odkaz:
https://doaj.org/article/23ac769d1d63464d85af6bdbd91fb365
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, José D. Villanueva-García, José A. Romero-Rosales, David Molina-García, Yannick Suter, Beatriz Asenjo, David Albillo, Ana Ortiz de Mendivil, Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Manuel Llorente, Natalia Carballo, Fátima Nagib-Raya, Maria Vidal-Denis, Belén Luque, Mauricio Reyes, Estanislao Arana, Víctor M. Pérez-García
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-6 (2023)
Abstract Brain metastasis (BM) is one of the main complications of many cancers, and the most frequent malignancy of the central nervous system. Imaging studies of BMs are routinely used for diagnosis of disease, treatment planning and follow-up. Art
Externí odkaz:
https://doaj.org/article/3bf38b90c0d541ebb693fa2533acc1aa
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, David Molina-García, Beatriz Asenjo, Ana Ortiz de Mendivil, David Albillo, Luís A Pérez-Romasanta, Elisabeth González del Portillo, Manuel Llorente, Natalia Carballo, Estanislao Arana, Víctor M Pérez-García
Publikováno v:
Neuro-Oncology Advances. 5
Background Radiation necrosis (RN) is a frequent adverse event after fractionated stereotactic radiotherapy (FSRT) or single-session stereotactic radiosurgery (SRS) treatment of brain metastases (BMs). It is difficult to distinguish RN from progressi
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, Juan Jiménez-Sánchez, David Molina García, Ana Ortiz de Mendivil, Beatriz Asenjo, David Albillo, Luís A. Pérez-Romasanta, Manuel Valiente, Lucía Zhu, Pedro García-Gómez, Elisabet González-Del Portillo, Manuel Llorente, Natalia Carballo, Estanislao Arana, Víctor M. Pérez-García
Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cdcce7185600a43e4e30592d880c4c0
https://doi.org/10.1101/2022.02.03.22270146
https://doi.org/10.1101/2022.02.03.22270146
Publikováno v:
Neuroradiology. 63(11)
Autor:
Pedro Galán Montenegro, Félix Navarro Guirado, Fátima Nagib Raya, Beatriz Asenjo García, Francisco Bravo Rodríguez, Maria Vidal Denis
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 61(3)
Background Recurrent high-grade gliomas progressing after surgery and temozolomide plus radiation therapy have traditionally been treated using antiangiogenic drugs as the first-line therapy. Since the phase 3 EORTC 26101 trial showed no significant
Autor:
Raquel Moreno, Belén Luque, Víctor M. Pérez-García, Ángel Rodríguez de Lope, Luis A. Pérez-Romasanta, Estanislao Arana, Araceli Henares-Molina, Julián Pérez-Beteta, Alicia Martínez-González, David Molina-García, Ismael Herruzo, David Albillo, Bárbara Meléndez-Asensio, Juan Martino, Carlos Velasquez, Beatriz Asenjo, Pedro C. Lara, Juan A. Barcia, Elena Arregui, Raquel Cabrera, Miguel Navarro, José M. Borrás, Manuel Calvo, Mariano Amo-Salas, Antonio Revert, Manuel Benavides
The original version of this article, published on 15 October 2018, unfortunately contained a mistake. The following correction has therefore been made in the original: The name of Mariano Amo-Salas and the affiliation of Ismael Herruzo were presente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358c17f417638a603b8061b3ce5cdcf1
https://link.springer.com/content/pdf/10.1007/s00330-018-5870-8.pdf
https://link.springer.com/content/pdf/10.1007/s00330-018-5870-8.pdf
Autor:
García, Beatriz Asenjo, Guirado, Félix Navarro, Raya, Fátima Nagib, Denis, María Vidal, Rodríguez, Francisco Bravo, Montenegro, Pedro Galán
Supplemental Material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56b5fded975b47184ce037afbf99767
Autor:
Mariano Amo-Salas, Miguel Navarro, Jose M. Villanueva, José M. Borrás, Luis A. Pérez-Romasanta, Philippe Schucht, Beatriz Asenjo, Estanislao Arana, Carlos López, Lidia Iglesias, Ismael Herruzo, Belén Luque, David Albillo, Víctor M. Pérez-García, Maria Delgado, Manuel Calvo, Marta Claramonte, Josué Avecillas, Elena Arregui, David Molina, Juan A. Barcia, Julián Pérez-Beteta, Ana del Valle, Anthony Falkov, Manuel Benavides, Alicia Martínez-González, Carlos Velasquez, Juan Martino, Juan Carlos Paniagua
Publikováno v:
Pérez-Beteta, Julián; Martínez-González, Alicia; Molina, David; Amo-Salas, Mariano; Luque, Belén; Arregui, Elena; Calvo, Manuel; Borrás, José M; López, Carlos; Claramonte, Marta; Barcia, Juan A; Iglesias, Lidia; Avecillas, Josué; Albillo, David; Navarro, Miguel; Villanueva, José M; Paniagua, Juan C; Martino, Juan; Velásquez, Carlos; Asenjo, Beatriz; ... (2017). Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study. European radiology, 27(3), pp. 1096-1104. Springer 10.1007/s00330-016-4453-9
BACKGROUND The potential of a tumour's volumetric measures obtained from pretreatment MRI sequences of glioblastoma (GBM) patients as predictors of clinical outcome has been controversial. Mathematical models of GBM growth have suggested a relation b